Moderna Inc (NASDAQ: MRNA) shares are trading lower by 7.78% to $123.66 going into the close of Wednesday's session on continued downward momentum and amid overall market weakness.
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Positive recommendation follows the recent approval of Spikevax bivalent Original/Omicron BA.1 (mRNA-1273.214), a bivalent booster vaccine targeting the Omicron BA.1 subvariant, in September
CAMBRIDGE, MA / ACCESSWIRE /
Data indicate durable immune response from bivalent booster after three months of follow-up
mRNA-1273.214 also demonstrated potent response to Omicron BA.2.75
CAMBRIDGE, MA / ACCESSWIRE / October 19, 2022
Moderna Inc (NASDAQ: MRNA) shares are trading lower by 4.11% to $133.52 going into the close of Tuesday's session after Morgan Stanley maintained an Equal-Weight rating on the stock and cut its price target from $197 to $175.
What Else?
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.